Vitamin D and calcium deficiency and its relationship with cardiac function in patients with beta thalassemia

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 41

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JKMU-31-1_005

تاریخ نمایه سازی: 27 اسفند 1402

Abstract:

Introduction: Heart disease is the main cause of mortality and morbidity in patients with beta thalassemia. Vitamin D and calcium deficiency also is common in these patients. We studied and compared vitamin D and calcium levels and other parameters with echocardiographic findings in patients with beta thalassemia. Method: A cross-sectional study in patients with Transfusion-dependent thalassemia was conducted. ۱۶۹ patients with Transfusion-dependent thalassemia were enrolled. Ejection fraction, valvular insufficiency and aortic diameter were determined. The aortic diameter of patients was measured using Mindray DC۶۰ echo model. All of these patients were tested for levels of vitamin D, calcium (Ca), parathyroid hormone (PTH), alkaline phosphatase (ALP), platelet (PLT), and ferritin, Finally, the effect of these factors on aortic root (AR), aortic valve area (AVA) and ejection fraction (EF) was evaluated. One-way ANOVA was used to compare quantitative variables, and chi-square test with ۹۵% confidence level was used to estimate relationships and compare ratios in groups. Results: There was a statistically significant relationship between vitamin D deficiency and Serum Ca (P-value = ۰.۰۰۹). Our results showed that with the increase in the level of vitamin D, the EF also increased and the probability that the aortic root will have a normal size will be higher. Furthermore, disorder in PTH and PLT level causes a decrease in the EF. Conclusion: This study did show an association between Vitamin D deficiency and cardiac function in patients with Transfusion-dependent thalassemia. Vitamin D can be considered as a supplement in thalassemia patients.

Authors

Maryam Ahmadipour

Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences

Ahmad Naghibzadeh-Tahami

Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Koroush Mirzie

Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran